Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: Improved potency via Trimerization

Journal of Virology

Volumn 76, Issue 4, 2002, Pages 1892-1903

  Kim, Jin ^a   Smith, Theodore ^a   Idamakanti, Neeraja ^a   Mulgrew, Kathy ^a   Kaloss, Michele ^a   Kylefjord, Helen ^a   Ryan, Patricia C ^a   Kaleko, Michael ^a   Stevenson, Susan C ^a  

^a NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ARGINYLGLYCYLASPARTIC ACID; LIGAND; VIRUS RECEPTOR; VIRUS VECTOR;

ADENOVIRUS; ARTICLE; BIOAVAILABILITY; COXSACKIE VIRUS; CROSS LINKING; GENE TARGETING; GENE TRANSFER; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ADENOVIRIDAE; ANIMALS; APOLIPOPROTEINS E; CELL LINE; GENE TARGETING; GENETIC VECTORS; HELA CELLS; HUMANS; LIVER; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; SOLUBILITY; TRANSDUCTION, GENETIC;

EID: 0036146390     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.4.1892-1903.2002     Document Type: Article

References (45)

1. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model
2. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
3. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses
4. Mosaic blood vessels in tumors: Frequency of cancer cells in contact with flowing blood
5. Fiber knob modifications overcome low, heterogeneous expression of the coxsackievirus-adenovirus receptor that limits adenovirus gene transfer and oncolysis for human rhabdomyosarcoma cells
6. Heparan sulfate glycosaminoglycans are involved in adenovirus type 5 and 2-host cell interactions
7. Ectodomain of coxsackievirus and adenovirus receptor genetically fused to epidermal growth factor mediates adenovirus targeting to epidermal growth factor receptor-positive cells
8. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
9. A system for the propagation of adenoviral vectors with genetically modified receptor specificities
10. Targeted gene delivery by tropism-modified adenoviral vectors
11. Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor
12. Construction of a pseudoreceptor that mediates transduction by adenoviruses expressing a ligand in fiber or penton base
13. Coxsackievirus and adenovirus receptor amino-terminal immunoglobulin V-related domain binds adenovirus type 2 and fiber knob from adenovirus type 12
14. Targeted gene delivery to Kaposi's sarcoma cells via the fibroblast growth factor receptor
15. Generation of an adenovirus vector lacking E1, e2a, E3, and all of E4 except open reading frame 3
16. Fibroblast growth factor 2 retargeted adenovirus has redirected cellular tropism: Evidence for reduced toxicity and enhanced antitumor activity in mice
17. A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutants
18. Enhanced gene transfer to rabbit jugular veins by an adenovirus containing a cyclic RGD motif in the HI loop of the fiber knob
19. Adenovirus type 5 viral particles pseudotyped with mutagenized fiber proteins show diminished infectivity of coxsackie B-adenovirus receptor-bearing cells
20. Transduction of dendritic cells by DNA viral vectors directs the immune response to transgene products in muscle fibers
21. Specifically targeted killing of carcinoembryonic antigen (CEA)-expressing cells by a retroviral vector displaying single-chain variable fragmented antibody to CEA and carrying the gene for inducible nitric oxide synthase
22. Mutations in the DG loop of adenovirus type 5 fiber knob protein abolish high-affinity binding to its cellular receptor CAR
23. Identification of contact residues and definition of the CAR-binding site of adenovirus type 5 fiber protein
24. Characterization of an adenovirus vector containing a heterologous peptidc epitope in the HI loop of the fiber knob
25. Genetic targeting of adenoviral vectors
26. Influence of adenoviral fiber mutations on viral encapsidation, infectivity and in vivo tropism
27. Kinetic analysis of adenovirus fiber binding to its receptor reveals an avidity mechanism for trimeric receptor-ligand interactions
28. Efficient adenoviral gene transfer to kidney cortical vasculature utilizing a fiber modified vector
29. Addition of a short peptide ligand to the adenovirus fiber protein
30. Evaluation of the concentration and bioactivity of adenovirus vectors for gene therapy
31. Cell receptors involved in adenovirus entry
32. An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo
33. Alpha v integrins as receptors for tumor targeting by circulating ligands
34. Fibroblast growth factor 2-retargeted adenoviral vectors exhibit a modified biolocalization pattern and display reduced toxicity relative to native adenoviral vectors
35. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector
36. Molecular determinants of adenovirus serotype 5 fibre binding to its cellular receptor CAR
37. Selective targeting of human cells by a chimeric adenovirus vector containing a modified fiber protein
38. Human adenovirus serotypes 3 and 5 bind to two different cellular receptors via the fiber head domain
39. A conditionally replicative adenovirus with enhanced infectivity shows improved oncolytic potency
40. The 'adenobody' approach to viral targeting: Specific and enhanced adenoviral gene delivery
41. Targeting endothelium for gene therapy via receptors up-regulated during angiogenesis and inflammation
42. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
43. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
44. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies
45. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins